Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Acute Ischemic Stroke Diagnosis and Treatment
... the year 2023, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Computed Tomography, one of the segments analyzed in the report, is expected to ... Read More
-
Angiography Devices
... at a CAGR of 3.8% over the analysis period 2023-2030. Angiography Systems, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.8 Billion by the end of ... Read More
-
Colposcopy
... of 4.0% over the analysis period 2023-2030. Cervical Cancer Screening Application, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$440.5 Million by the end of the ... Read More
-
Nicotine Gum
... at a CAGR of 4.8% over the analysis period 2023-2030. 2 mg Nicotine Gum, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$5.0 Billion by the ... Read More
-
Opioids
... of 2.3% over the analysis period 2023-2030. Extended-Release / Long-Acting Opioids, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$18.7 Billion by the end of the ... Read More
-
Cognitive Assessment and Training
... reach US$31.0 Billion by 2030, growing at a CAGR of 27.1% over the analysis period 2023-2030. Solutions Component, one of the segments analyzed in the report, is expected to record a 25.1% CAGR and reach ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More
-
Gynecological Cancer Drugs
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Cervical Cancer Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$10.3 Billion ... Read More
-
Hip Resurfacing Implants
... by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Hybrid Alloy Material, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$128.9 Million ... Read More
-
Human Papillomavirus (HPV) Testing
... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... US$9.1 Billion in the year 2023, is expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.5 Billion While China ... Read More
-
Non-Infectious Macular Edema Treatment
... reach US$25.0 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Anti-VEGF Drug, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach ... Read More
-
Nursing Breast Pads
... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Reusable Nursing Breast Pads, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$220.4 ... Read More
-
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
... US accounted for approximately 37% of the cases, EU4 and the UK countries accounted for around 54%, followed by Japan which represented nearly 9%. DelveInsight’s estimates indicate that in 2023, there were approximately 77,445 diagnosed ... Read More
-
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034
... USD 12 billion which is further expected to rise at a CAGR of 2.8% by 2034. In 2023, the diagnosed prevalence of Atherosclerotic Cardiovascular Disease (ASCVD) was highest in the US among the 7MM, accounting ... Read More
-
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034
... virus infection in the 7MM is expected to increase, driven by increasing Incident population. DelveInsight’s analyst projects that the total Incident Cases of Parainfluenza Virus in 7MM were approximately 2,709,923 in 2023 and these cases ... Read More
-
Orthodontic Services
... CAGR of 11.5% over the analysis period 2023-2030. Removable Orthodontic Services, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$7.7 Billion by the end of the ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2023-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Women's Health Rehabilitation Products
... 2030, growing at a CAGR of 1.2% over the analysis period 2023-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$731.9 Million by ... Read More
-
Anxiolytics
... 4.6% over the analysis period 2023-2030. The U.S. Market is Estimated at US$250.6 Million While China is Forecast to Grow at 7.1% CAGR The Anxiolytics market in the U.S. is estimated at US$250.6 Million in ... Read More
-
Disruptive Behavior Disorder (DBD) Treatment
... Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Oppositional Defiant Disorder, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$19.2 ... Read More
-
Interventional Oncology Devices
... at a CAGR of 6.3% over the analysis period 2023-2030. Embolization Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.4 Billion by the end of ... Read More
-
Male Infertility
... CAGR of 5.8% over the analysis period 2023-2030. DNA Fragmentation Technique, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Hyaluronic Acid-based Dermal Fillers
... 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Single Phase Hyaluronic Acid-based Dermal Fillers, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach ... Read More
-
Neurovascular Devices / Interventional Neurology
... is expected to reach US$6.1 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Aneurysm Coiling & Embolization Devices, one of the segments analyzed in the report, is expected to ... Read More
Research Assistance
